Literature DB >> 31017305

Secondary prevention after stroke/transient ischemic attack: A randomized audit and feedback trial.

Lukas Geary1,2,3, Jan Hasselström4,5, Axel Carl Carlsson4, Irene Eriksson6,7, Mia von Euler1,2,7,8.   

Abstract

OBJECTIVES: The clinical benefits of use of secondary preventive pharmacotherapy in ischemic stroke/TIA have been previously demonstrated. A potential target for facilitating the use of recommended medications is primary care physicians. Therefore, we carried out an audit and feedback intervention aimed at primary care centers. The aim was to improve the use of secondary preventive stroke medications and diagnosis recording in ischemic stroke/TIA.
MATERIALS AND METHODS: The intervention consisted of structured, healthcare database-derived quality reports on secondary preventive medication use and diagnosis recording, sent in 2015 to half of the primary care centers in Stockholm County, with information specific to each primary care center. Medication dispensation (primary outcome) for statins, antihypertensives, antiplatelets, and anticoagulants, as well as diagnosis recording (secondary outcome), was compared between intervention centers and control centers in the 18 months following the intervention. Outcome data were derived from the healthcare databases of Stockholm County (VAL).
RESULTS: Dispensation of medications to the 12 766 patients analyzed in the study was high. Over 77% of patients used antihypertensives and antithrombotics, and 65%-68% used statins. After the intervention, no differences in medication dispensation were seen between the intervention and control centers, even after adjusting for potential confounders.
CONCLUSIONS: A simple audit and feedback intervention directed toward physicians in primary care did not improve medication dispensation to ischemic stroke/TIA patients 18 months later. Any future audit and feedback intervention aimed at improving adherence to guidelines for secondary prevention in primary care should consider multiple and continuous reminders, the graphical appeal, and widening the recipients to include patients.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  diagnosis recording; drug therapy; general practitioners; physicians; primary care; primary health care; secondary prevention; stroke; transient ischemic attack

Mesh:

Substances:

Year:  2019        PMID: 31017305     DOI: 10.1111/ane.13109

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Annual and Post-Exacerbation Follow-Up of Asthma Patients in Clinical Practice - A Large Population-Based Study in Sweden.

Authors:  Hanna Sandelowsky; Björn Ställberg; Fredrik Wiklund; Gunilla Telg; Sofie de Fine Licht; Christer Janson
Journal:  J Asthma Allergy       Date:  2022-04-13

2.  Thirty-six months recurrence after acute ischemic stroke among patients with comorbid type 2 diabetes: A nested case-control study.

Authors:  Lu Wang; Hongyun Li; Jiheng Hao; Chao Liu; Jiyue Wang; Jingjun Feng; Zheng Guo; Yulu Zheng; Yanbo Zhang; Hongxiang Li; Liyong Zhang; Haifeng Hou
Journal:  Front Aging Neurosci       Date:  2022-09-30       Impact factor: 5.702

3.  Planned primary health care asthma contacts during 12-year follow-up after Finnish National Asthma Programme: focus on spirometry.

Authors:  Jaana Takala; Pinja Ilmarinen; Leena E Tuomisto; Iida Vähätalo; Onni Niemelä; Hannu Kankaanranta
Journal:  NPJ Prim Care Respir Med       Date:  2020-03-20       Impact factor: 2.871

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.